Persistence of male hematopoietic CD34+ cells in the circulation of women does not affect prenatal diagnostic techniques

Fetal hematopoietic CD34+ cells can be used in the noninvasive prenatal testing of fetal aneuploidies because the presence of fetal microchimerism does not affect fetal diagnosis in current pregnancies.